FDA issues recall for Zantac after confirming the medication can breakdown to create NDMA a known carcinogen. On April 1st, 2020 the FDA issues the following statement. "The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly kn

Recent studies have raised concern after showing Zantac may react with itself to form a cancer causing compound known as NDMA. | Lawsuit Watch